跳至主要内容
临床试验/EUCTR2009-014280-38-GB
EUCTR2009-014280-38-GB进行中(未招募)1 期

A randomised controlled trial of standard and low dose Avastin® for Neovascular Macular Degeneration in the East Midlands - TANDEM: RCT of standard & low dose Avastin for MD in East Midlands

ottingham University Hospitals NHS Trust0 个研究点目标入组 812 人开始时间: 2010年8月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
812

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Any patient newly referred for the treatment of nAMD or reactivation of nAMD, i.e. disease stable with no treatment for nAMD to either eye for the previous 6 months, who is considered eligible for anti-VEGF treatment in the NHS.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 600
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1400

排除标准

  • Pregnant and or lactating women • Women with child bearing potential (i.e. not sterilised or not post menopausal) who are unwilling to use contraception • Men with a spouse or partner with child bearing potential unless the participant has agreed to use condoms • Patients with known hypersensitivity to recombinant human or humanised antibodies

研究者

发起方
ottingham University Hospitals NHS Trust

相似试验